Table 2.
Profile of phenotype antimicrobial resistance of H. pylori clinical isolates
| Phenotype Susceptibility Profile | Antibiotic | N | % | |
|---|---|---|---|---|
| Susceptibility to all antibiotics | 9 | 13.8 | ||
| Single drug resistance | CLR | 7 | 10.8 | |
| LVX | 2 | 3.1 | ||
| MNZ | 14 | 21.5 | ||
| RIF | 1 | 1.5 | ||
| TET | 1 | 1.5 | ||
| Dual drug resistance | CLR + LVX | 3 | 4.6 | |
| CLR + MNZ | 7 | 10.8 | ||
| LVX + MNZ | 4 | 6.2 | ||
| LVX + RIF | 1 | 1.5 | ||
| MNZ + AMO | 2 | 3.1 | ||
| MNZ + RIF | 3 | 4.6 | ||
| Multidrug resistance | CLR + LVX + MNZ | 4 | 6.2 | |
| CLR + MNZ + AMO | 1 | 1.5 | ||
| CLR + MNZ + RIF | 1 | 1.5 | ||
| LVX + MNZ + AMO | 2 | 3.1 | ||
| LVX + MNZ + RIF | 1 | 1.5 | ||
| LVX + MNZ + TET | 1 | 1.5 | ||
| CLR + LVX + MNZ + RIF | 1 | 1.5 | ||